Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0140513 | nuclear protein-containing complex | 2 | 12 |
GO:1990904 | ribonucleoprotein complex | 2 | 12 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005684 | U2-type spliceosomal complex | 4 | 1 |
GO:0005686 | U2 snRNP | 5 | 1 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 1 |
GO:0071004 | U2-type prespliceosome | 5 | 1 |
GO:0071010 | prespliceosome | 4 | 1 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 1 |
GO:0097525 | spliceosomal snRNP complex | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0120114 | Sm-like protein family complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A4HEF0
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 12 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 12 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 12 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006397 | mRNA processing | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0008380 | RNA splicing | 7 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016071 | mRNA metabolic process | 6 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0045292 | mRNA cis splicing, via spliceosome | 9 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 19 | 23 | PF00656 | 0.528 |
CLV_C14_Caspase3-7 | 85 | 89 | PF00656 | 0.647 |
CLV_NRD_NRD_1 | 136 | 138 | PF00675 | 0.659 |
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.566 |
CLV_NRD_NRD_1 | 215 | 217 | PF00675 | 0.339 |
CLV_NRD_NRD_1 | 257 | 259 | PF00675 | 0.427 |
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.442 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.529 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.659 |
CLV_PCSK_KEX2_1 | 215 | 217 | PF00082 | 0.459 |
CLV_PCSK_KEX2_1 | 256 | 258 | PF00082 | 0.427 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.453 |
CLV_PCSK_KEX2_1 | 379 | 381 | PF00082 | 0.649 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.456 |
CLV_PCSK_PC1ET2_1 | 123 | 125 | PF00082 | 0.435 |
CLV_PCSK_PC1ET2_1 | 379 | 381 | PF00082 | 0.649 |
CLV_PCSK_PC1ET2_1 | 48 | 50 | PF00082 | 0.443 |
CLV_PCSK_SKI1_1 | 215 | 219 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 248 | 252 | PF00082 | 0.419 |
CLV_PCSK_SKI1_1 | 258 | 262 | PF00082 | 0.407 |
CLV_Separin_Metazoa | 126 | 130 | PF03568 | 0.540 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.691 |
DEG_SPOP_SBC_1 | 165 | 169 | PF00917 | 0.535 |
DEG_SPOP_SBC_1 | 315 | 319 | PF00917 | 0.676 |
DEG_SPOP_SBC_1 | 356 | 360 | PF00917 | 0.690 |
DEG_SPOP_SBC_1 | 99 | 103 | PF00917 | 0.558 |
DOC_CKS1_1 | 332 | 337 | PF01111 | 0.493 |
DOC_CYCLIN_RxL_1 | 213 | 224 | PF00134 | 0.579 |
DOC_MAPK_gen_1 | 151 | 158 | PF00069 | 0.562 |
DOC_MAPK_gen_1 | 280 | 289 | PF00069 | 0.580 |
DOC_MAPK_gen_1 | 48 | 55 | PF00069 | 0.411 |
DOC_PP1_RVXF_1 | 214 | 221 | PF00149 | 0.468 |
DOC_PP1_RVXF_1 | 268 | 274 | PF00149 | 0.428 |
DOC_PP2B_LxvP_1 | 351 | 354 | PF13499 | 0.563 |
DOC_PP4_FxxP_1 | 311 | 314 | PF00568 | 0.719 |
DOC_USP7_MATH_1 | 315 | 319 | PF00917 | 0.720 |
DOC_USP7_MATH_1 | 337 | 341 | PF00917 | 0.659 |
DOC_USP7_MATH_1 | 356 | 360 | PF00917 | 0.744 |
DOC_USP7_UBL2_3 | 119 | 123 | PF12436 | 0.424 |
DOC_USP7_UBL2_3 | 175 | 179 | PF12436 | 0.431 |
DOC_WW_Pin1_4 | 310 | 315 | PF00397 | 0.704 |
DOC_WW_Pin1_4 | 331 | 336 | PF00397 | 0.680 |
LIG_14-3-3_CanoR_1 | 215 | 221 | PF00244 | 0.551 |
LIG_14-3-3_CanoR_1 | 270 | 276 | PF00244 | 0.591 |
LIG_14-3-3_CanoR_1 | 283 | 289 | PF00244 | 0.622 |
LIG_AP2alpha_2 | 141 | 143 | PF02296 | 0.489 |
LIG_BRCT_BRCA1_1 | 312 | 316 | PF00533 | 0.476 |
LIG_BRCT_BRCA1_1 | 357 | 361 | PF00533 | 0.725 |
LIG_BRCT_BRCA1_1 | 57 | 61 | PF00533 | 0.480 |
LIG_CtBP_PxDLS_1 | 14 | 20 | PF00389 | 0.425 |
LIG_eIF4E_1 | 365 | 371 | PF01652 | 0.683 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.521 |
LIG_FHA_1 | 153 | 159 | PF00498 | 0.521 |
LIG_FHA_1 | 279 | 285 | PF00498 | 0.576 |
LIG_FHA_1 | 328 | 334 | PF00498 | 0.580 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.505 |
LIG_FHA_1 | 7 | 13 | PF00498 | 0.395 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.571 |
LIG_FHA_2 | 225 | 231 | PF00498 | 0.510 |
LIG_FHA_2 | 239 | 245 | PF00498 | 0.310 |
LIG_FHA_2 | 261 | 267 | PF00498 | 0.442 |
LIG_LIR_Apic_2 | 310 | 314 | PF02991 | 0.577 |
LIG_LIR_Gen_1 | 274 | 284 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 212 | 217 | PF02991 | 0.514 |
LIG_LIR_Nem_3 | 274 | 279 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 358 | 364 | PF02991 | 0.604 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.374 |
LIG_MYND_1 | 76 | 80 | PF01753 | 0.501 |
LIG_PCNA_yPIPBox_3 | 268 | 279 | PF02747 | 0.563 |
LIG_Pex14_2 | 61 | 65 | PF04695 | 0.341 |
LIG_PTB_Apo_2 | 188 | 195 | PF02174 | 0.478 |
LIG_RPA_C_Fungi | 22 | 34 | PF08784 | 0.452 |
LIG_SH2_CRK | 214 | 218 | PF00017 | 0.363 |
LIG_SH2_NCK_1 | 249 | 253 | PF00017 | 0.386 |
LIG_SH2_STAP1 | 172 | 176 | PF00017 | 0.360 |
LIG_SH2_STAP1 | 249 | 253 | PF00017 | 0.386 |
LIG_SH2_STAP1 | 347 | 351 | PF00017 | 0.498 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.281 |
LIG_SH2_STAT5 | 237 | 240 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.374 |
LIG_SH3_3 | 326 | 332 | PF00018 | 0.705 |
LIG_SH3_3 | 77 | 83 | PF00018 | 0.591 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.413 |
LIG_SUMO_SIM_par_1 | 154 | 159 | PF11976 | 0.496 |
LIG_TRAF2_1 | 263 | 266 | PF00917 | 0.448 |
LIG_WRC_WIRS_1 | 217 | 222 | PF05994 | 0.341 |
LIG_WRC_WIRS_1 | 279 | 284 | PF05994 | 0.491 |
MOD_CK1_1 | 318 | 324 | PF00069 | 0.587 |
MOD_CK1_1 | 340 | 346 | PF00069 | 0.562 |
MOD_CK1_1 | 67 | 73 | PF00069 | 0.506 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.655 |
MOD_CK2_1 | 216 | 222 | PF00069 | 0.509 |
MOD_CK2_1 | 224 | 230 | PF00069 | 0.482 |
MOD_CK2_1 | 238 | 244 | PF00069 | 0.336 |
MOD_CK2_1 | 260 | 266 | PF00069 | 0.455 |
MOD_Cter_Amidation | 377 | 380 | PF01082 | 0.740 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.466 |
MOD_GlcNHglycan | 339 | 342 | PF01048 | 0.599 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.630 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.559 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.411 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.503 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.643 |
MOD_GSK3_1 | 327 | 334 | PF00069 | 0.486 |
MOD_GSK3_1 | 337 | 344 | PF00069 | 0.669 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.624 |
MOD_N-GLC_1 | 307 | 312 | PF02516 | 0.517 |
MOD_NEK2_1 | 112 | 117 | PF00069 | 0.686 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.285 |
MOD_NEK2_1 | 210 | 215 | PF00069 | 0.295 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.518 |
MOD_NEK2_1 | 271 | 276 | PF00069 | 0.561 |
MOD_NEK2_1 | 316 | 321 | PF00069 | 0.635 |
MOD_NEK2_1 | 366 | 371 | PF00069 | 0.577 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.514 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.282 |
MOD_PIKK_1 | 231 | 237 | PF00454 | 0.460 |
MOD_PKA_2 | 128 | 134 | PF00069 | 0.572 |
MOD_PKA_2 | 26 | 32 | PF00069 | 0.533 |
MOD_PKA_2 | 282 | 288 | PF00069 | 0.558 |
MOD_Plk_1 | 156 | 162 | PF00069 | 0.526 |
MOD_Plk_1 | 307 | 313 | PF00069 | 0.682 |
MOD_Plk_1 | 55 | 61 | PF00069 | 0.374 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.488 |
MOD_Plk_4 | 307 | 313 | PF00069 | 0.648 |
MOD_Plk_4 | 366 | 372 | PF00069 | 0.577 |
MOD_Plk_4 | 6 | 12 | PF00069 | 0.636 |
MOD_ProDKin_1 | 310 | 316 | PF00069 | 0.706 |
MOD_ProDKin_1 | 331 | 337 | PF00069 | 0.680 |
MOD_SUMO_for_1 | 122 | 125 | PF00179 | 0.408 |
MOD_SUMO_rev_2 | 148 | 153 | PF00179 | 0.630 |
MOD_SUMO_rev_2 | 84 | 89 | PF00179 | 0.602 |
TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.389 |
TRG_ER_diArg_1 | 136 | 138 | PF00400 | 0.668 |
TRG_ER_diArg_1 | 214 | 216 | PF00400 | 0.441 |
TRG_ER_diArg_1 | 256 | 258 | PF00400 | 0.521 |
TRG_ER_diArg_1 | 267 | 270 | PF00400 | 0.480 |
TRG_Pf-PMV_PEXEL_1 | 137 | 141 | PF00026 | 0.510 |
TRG_Pf-PMV_PEXEL_1 | 216 | 221 | PF00026 | 0.358 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HXM6 | Leptomonas seymouri | 71% | 100% |
A0A0S4IPX0 | Bodo saltans | 36% | 86% |
A0A1X0NNP0 | Trypanosomatidae | 44% | 80% |
A0A3R7KXN8 | Trypanosoma rangeli | 48% | 88% |
A0A3S7WZ46 | Leishmania donovani | 88% | 100% |
A4I1I4 | Leishmania infantum | 88% | 100% |
C9ZJY4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9AXL9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4Q9V3 | Leishmania major | 88% | 100% |
V5BCN7 | Trypanosoma cruzi | 46% | 81% |